1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
The Clinical and Translational Science AI Innovation Award is an NCATS CTSA-funded pilot mechanism administered by The Ohio State University Center for Clinical and Translational Science, providing up to 125,000 US dollars in direct costs per year across a 24-month project period for a maximum of 250,000 dollars.
It is one of the larger institutional AI pilot awards in the CTSA network, where comparable programmes commonly cap at 25,000 to 50,000 dollars, which makes it worth tracking as a model for how CTSA hubs are funding clinical AI.
Projects must employ an innovative AI or data science approach or technology that drives translational science and must address an identified translational research barrier; the award explicitly excludes pre-clinical research, so bench-only machine learning projects are out of scope, and review weighs both innovation and equity. All work must be completed within the 24-month window, which rules out designs with long accrual timelines.
Eligibility is institutional: multiple principal investigators must hold PI status at Ohio State or Nationwide Children's Hospital, must be CTSI members at full-application stage with human subjects protection training complete, and are disqualified if they have received a CTSI pilot award activated on or after 1 August 2025 or a prior CTS-AI Award activated on or after 1 August 2024.
The programme uses a two-stage process in which full applications are by invitation following pre-application review; awardees face firm compliance milestones, meeting the Regulatory Program Manager by 15 March 2027 and submitting to the Institutional Review Board by 31 March 2027.
The deadline recorded here reflects that award-cycle milestone rather than a published pre-application date, which the Center has not posted, so applicants should confirm the current pre-application window with the Center directly.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Multiple principal investigators must hold PI status at The Ohio State University or Nationwide Children's Hospital and be CTSI members with completed human subjects protection training at full-application stage. Investigators who received a CTSI pilot award activated on or after 1 August 2025, or a CTS-AI Award activated on or after 1 August 2024, are ineligible. Full applications are by invitation after pre-application review; pre-clinical research is excluded. Confirm the full requirements in the official notice before applying.
The current listing shows up to $125,000 in direct costs per year for two years, to a maximum of $250,000 total. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Applications for Ohio State 2027 Clinical and Translational Science AI Innovation (CTS-AI) Award for AI and Data Science Approaches Removing Translational Research Barriers are due March 15, 2027. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
Ohio State 2027 Clinical and Translational Science AI Innovation (CTS-AI) Award for AI and Data Science Approaches Removing Translational Research Barriers is funded by National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) Clinical and Translational Science Awards Program, administered by The Ohio State University Center for Clinical and Translational Science. Verify program details on the funder's official page before applying.
This opportunity targets applicants in OH. If your organization operates elsewhere, check the official notice for location requirements.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
The DARPA Surgical Competition (DSC) is a $3.5 million prize challenge run by DARPA's Biological Technologies Office under 10 U.S.C. 4025. Its goal is to advance robotic and AI-enabled surgical systems that can deliver trauma care closer to the point of injury with fewer specialists available. There are two lanes. Lane 1, surgical collaboration, covers robots that assist a surgeon. Lane 2, surgical independence, covers robots performing surgical tasks with increasing autonomy. In each lane, first place wins $1 million, second $400,000, and third $100,000. Component gate prizes are $235,000 for the top Physical Capability Gate performer, $100,000 for the Rapid Learning Gate, and $75,000 for the Medical Knowledge Gate, and teams meeting each gate's minimums receive $3,000 per gate. Up to 10 teams will qualify. The qualification window runs from 11 September 2026 and closes on 13 November 2026 at 4 PM ET, with rolling review. The schedule also includes a virtual second industry day on 4 November 2026, an in-person workshop on 15-24 January 2027, and the scored competition on 20-26 March 2027. Teams are self-funded, and there is no full proposal and no cost share.
NSF's Dear Colleague Letter NSF 26-017 (published March 24, 2026, updated October 27, 2026) invites proposals that use AI and other emerging technologies to strengthen children's online safety and privacy, expand educational opportunities, support well-being, and help educators and parents, including through AI literacy and digital literacy. The DCL has no dedicated budget. Proposals are submitted through participating programs such as NSF FINDERS Foundry (NSF 26-507), which expects about 50 Planning awards of up to $50,000 and about 20 Development awards of up to $300,000 for one year, and TechAccess: AI-Ready America (NSF 26-508). Proposal titles must begin 'Empowering Children to Thrive DCL:'. The next FINDERS Foundry Development proposal deadline is November 18, 2026 at 5 p.m. submitter local time; other deadlines follow the participating solicitations.
The National Geospatial-Intelligence Agency (NGA) Rapid Capabilities Office, working with the Office of Naval Intelligence and Army Contracting Command-Rock Island, is running a One Nation Innovation challenge on the GoColosseum marketplace. The challenge is Tactical ISR Processing, Exploitation and Dissemination (PED): Adaptive AI and Autonomy at the Tactical Edge. It seeks AI and computer vision that detect, track, and re-identify objects in imagery from small unclassified unmanned aerial systems. Systems must keep custody across multiple simultaneous detections and re-identify targets after custody is lost. They must also use low-shot learning that needs minimal labelled data, run at the edge on size-, weight- and power-constrained hardware without the cloud, and integrate with GEOINT formats and the Tactical Assault Kit (TAK). Winning solutions may receive prototype awards under Other Transaction Authority, and the amount and number of awards are not published. The submission window opened on 22 October 2026 and closes on 19 November 2026 at 3:00 PM CST. Applicants must join GoColosseum to apply.
RFA-EB-28-004, NextTech: Translational Development of Next-Generation Diagnostic and Therapeutic Devices (R18), puts about $6 million into 8 to 12 BRAIN and HEAL Initiative device-development awards. Budgets should rarely exceed $750,000 in direct costs a year, projects run up to three years, nine institutes participate, and there are six due dates from February 1, 2027 through February 1, 2030. Here is what the program requires and how to write a competitive application.
Read articlePAR-27-056 replaces the long-running IDeA-CTR U54 cooperative agreement with a P30 center core grant and splits the program into Development and Network tracks. Posted August 19, 2026, with a first estimated due date of October 9. Here is what the mechanism swap actually changes for the 23 IDeA states and Puerto Rico.
Read articleNOT-OD-26-098 consolidates NIH career development awards into four parent NOFOs (KR1, KC1, KS1, KT1), eliminates the Data Management and Sharing Plan for K applications, and stops supporting K awards that let the awardee lead their own clinical trial. The RFI closes September 30, 2026; the new structure hits due dates on or after October 12, 2027.
Read article